Imaging-based Biomarkers as Predictors of Response to Anti-VEGF Therapy in Idiopathic Choroidal Neovascularization

被引:0
|
作者
Agrawal, Surbhi [1 ]
Chawla, Rohan [1 ]
Todi, Vishnu [1 ]
Vohra, Rajpal [1 ]
Azad, Shorya V. [1 ]
机构
[1] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India
关键词
Anti-VEGF; biomarkers; idiopathic choroidal neovascularization; OCT; OCT-A; GROWTH-FACTOR THERAPY; INTRAVITREAL BEVACIZUMAB; PHOTODYNAMIC THERAPY; RANIBIZUMAB; ANGIOGRAPHY; RECURRENCE; TYPE-1;
D O I
10.4103/meajo.meajo_173_21
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: The purpose of this study was to identify biomarkers that predict the response of treatment-naive idiopathic choroidal neovascularization (iCNV) to anti-VEGF treatment.METHODS: Fourteen eyes diagnosed with iCNV underwent a dilated fundus examination, Swept Source Optical Coherence Tomography (SS-OCT) and Optical Coherence Tomography - Angiography (OCT-A), and were given an anti-VEGF injection. The same examinations were repeated at every follow-up visit. Analysis of the pre- and posttreatment images was done to identify possible biomarkers which were evaluated to check association with decreased need for multiple anti-VEGF injections.RESULTS: At presentation, 11 patients showed a compact pattern, while three patients showed an arborizing pattern on OCT angiography (P = 1). On follow-up imaging, seven patients showed a marked response, five patients showed a moderate response, and two patients showed a mild response to anti-VEGF injection. Among the seven patients showing a marked response, only one required a repeat injection (P = 0.03). On analysis of SS-OCT, a novel Retinal Pigment Epithelium (RPE) healing response was observed in posttreatment imaging of six patients (P = 0.59).CONCLUSION: A "marked" response to the first anti-VEGF injection results in a more sustained response and is a positive prognostic factor. RPE healing response is an interesting observation that merits further evaluation. Morphology of neovascular membranes has no effect on long-term need for multiple anti-VEGF injections.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 50 条
  • [1] Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization
    Xiaojuan Fan
    Ning Gao
    Jingming Li
    Jianqin Lei
    Qianyan Kang
    [J]. Molecular and Cellular Biochemistry, 2018, 441 : 173 - 179
  • [2] Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization
    Fan, Xiaojuan
    Gao, Ning
    Li, Jingming
    Lei, Jianqin
    Kang, Qianyan
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 441 (1-2) : 173 - 179
  • [3] The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization
    Chen, Qin
    Yu, Xiaobing
    Sun, Zihan
    Dai, Hong
    [J]. JOURNAL OF OPHTHALMOLOGY, 2016, 2016
  • [4] Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy
    Kelvin Yi Chong Teo
    Wei Yan Ng
    Shu Yen Lee
    Chui Ming Gemmy Cheung
    [J]. Drugs, 2016, 76 : 1119 - 1133
  • [5] Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy
    Teo, Kelvin Yi Chong
    Ng, Wei Yan
    Lee, Shu Yen
    Cheung, Chui Ming Gemmy
    [J]. DRUGS, 2016, 76 (11) : 1119 - 1133
  • [6] Safety and Efficacy of Anti-VEGF Therapy for Choroidal Neovascularization Overlying Choroidal Osteoma
    Khan, Mohammed
    DeCroos, Francis
    Storey, Philip
    Shields, Jerry
    Garg, Sunir
    Shields, Carol
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [7] AMD associated Peripapillary Choroidal Neovascularization in the era of anti-VEGF therapy
    Lin, Tiezhu
    Dans, Kunny C.
    Meshi, Amit
    Amador, Manuel
    Freeman, William R.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [8] Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization
    Ng, Danny S. C.
    Ho, Mary
    Iu, Lawrence P. L.
    Lai, Timothy Y. Y.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 43 - 54
  • [9] Anti-VEGF PolysiRNA Polyplex for the Treatment of Choroidal Neovascularization
    Lee, Jihwang
    Ryoo, Na-kyung
    Han, Hyounkoo
    Hong, Hye Kyoung
    Park, Ji Yeon
    Park, Sang Jun
    Kim, Yong-Kyu
    Sim, Changbeom
    Kim, Kwangmeyung
    Woo, Se Joon
    Park, Kyu Hyung
    Kim, Hyuncheol
    [J]. MOLECULAR PHARMACEUTICS, 2016, 13 (06) : 1988 - 1995
  • [10] Novel Predictors of Visual Outcome in Anti-VEGF Therapy for Myopic Choroidal Neovascularization Derived Using OCT Angiography
    Hosoda, Yoshikatsu
    Miyata, Manabu
    Uji, Akihito
    Ooto, Sotaro
    Yamashiro, Kenji
    Tamura, Hiroshi
    Oishi, Akio
    Ueda-Arakawa, Naoko
    Miyake, Masahiro
    Hata, Masayuki
    Muraoka, Yuki
    Takahashi, Ayako
    Tsujikawa, Akitaka
    [J]. OPHTHALMOLOGY RETINA, 2018, 2 (11): : 1118 - 1124